NCT06134375 2026-03-12
A Study of Tetrathiomolybdate (TM) Plus Capecitabine
Dartmouth-Hitchcock Medical Center
Phase 1/2 Recruiting
Clinical Trials
11 trialsNCT00195091 2025-05-16
Phase II Study of Tetrathiomolybdate (TM) in Patients With Breast Cancer
Memorial Sloan Kettering Cancer Center
Phase 2 Terminated
NCT01837329 2019-07-19
Phase I Study of Tetrathiomolybdate in Combination With Carboplatin/Pemetrexed in Metastatic Non-small Cell Lung Cancer
University of Rochester
Phase 1 Completed
NCT00176800 2016-08-22
Chemoradiation and Tetrathiomolybdate (TM) in Patients With Esophageal Carcinoma
University of Michigan Rogel Cancer Center
Phase 2 Completed
NCT00150995 2015-01-21
Tetrathiomolybdate in Hormone Refractory Prostate Cancer
University of Michigan Rogel Cancer Center
Phase 2 Completed
NCT00674557 2013-07-10
Exemestane With or Without ATN-224 in Treating Postmenopausal Women With Recurrent or Advanced Breast Cancer
National Cancer Institute (NCI)
Phase 2 Terminated
NCT00176774 2012-02-07
Irinotecan, 5-Fluorouracil, and Leucovorin in Colorectal Carcinoma
University of Michigan Rogel Cancer Center
Phase 2 Completed
NCT00352742 2008-10-28
A Study of ATN-224 and Bortezomib in Patients With Multiple Myeloma
Attenuon
Phase 1/2 Terminated
NCT00405574 2008-01-30
Study of ATN-224 in Patients With Prostate Cancer
Attenuon
Phase 2 Unknown
NCT00383851 2007-12-06
Randomized Trial of ATN-224 and Temozolomide in Advanced Melanoma
Attenuon
Phase 2 Unknown
NCT00006332 2005-06-24
Treatment of Hepatocellular Carcinoma With Tetrathiomolybdate
National Center for Research Resources (NCRR)
Phase 2 Completed